Hot Stock List: Eastman Chemical Co. (NYSE:EMN), Public Storage (NYSE:PSA), Ariad Pharmaceuticals (NASDAQ:ARIA), Compass Diversified (NYSE:CODI), Caesars Acquisition (NASDAQ:CACQ), Stemline Therapeutics (NASDAQ:STML)


On Thursday shares of Eastman Chemical Co. (NYSE:EMN) closed at $76.22. Company’s sales growth for last 5 years was 16.70% and EPS growth for next 5 years is recorded as 8.04%. Eastman Chemical Co. (NYSE:EMN) reported net income for the first quarter of $171 million or $1.14 per share, compared to $233 million or $1.52 per share for the year-ago quarter.

Public Storage (NYSE:PSA) in last trading activity moved down -0.35% to close at $187.91. Company weekly performance is -2.66% while its quarterly performance stands at -7.27%. Public Storage (NYSE:PSA) is -8.50% away from its 52 week high. Public Storage (NYSE:PSA) on Thursday reported a key measure of profitability in its first quarter. The results did not meet Wall Street expectations. The real estate investment trust, based in Glendale, California, said it had funds from operations of $331.1 million, or $1.91 per share, in the period.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in last trading activity decreased -6.07% to close at $8.67. Company weekly performance is -9.88% while its quarterly performance stands at 34.63%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is -12.34% away from its 52 week high. Ariad Pharmaceuticals (NASDAQ:ARIA) Chief Executive Officer Harvey Berger will retire this year in a settlement with activist hedge fund Sarissa Capital, capping months of agitation against the cancer drug maker.

On last trading day Compass Diversified Holdings (NYSE:CODI) decreased -0.35% to close at $17.22. Its volatility for the week is 1.16% while volatility for the month is 1.24%. CODI’s sales growth for past 5 years was 14.30% and its EPS growth for past 5 years was 251.90%. Compass Diversified Holdings (NYSE:CODI) monthly performance is 2.82%. Compass Diversified Holdings (NYSE:CODI) announced that Alan Offenberg, Chief Executive Officer, and Ryan J. Faulkingham, Chief Financial Officer, are scheduled to present at the Houlihan Lokey 10th Annual Global Industrials Conference in New York, NY on Wednesday, May 6, 2015 at 2:45 p.m. ET.

On last trading day Stemline Therapeutics, Inc. (NASDAQ:STML) decreased -6.72% to close at $13.89. Its volatility for the week is 7.51% while volatility for the month is 4.86%. STML’s EPS growth for past 5 years was -16.90%. Stemline Therapeutics, Inc. (NASDAQ:STML) monthly performance is -4.01%.HC Wainright started coverage on shares of Stemline Therapeutics (NASDAQ:STML) in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $38.00 price target on the stock.


Leave a Reply

Your email address will not be published. Required fields are marked *